TLR4 and bacterial infectious disease: Therefore, we analyzed the effect of the newly identified TLR4 antagonist on the cytokine response in human peripheral blood mononuclear cells (PBMCs) and in human whole blood in the presence of LPS as activating molecule, mimicking bacterial infection.